Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mucosal Lentiginous Melanoma × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 776 Lymphoma, T-Cell, Cutaneous 130 Uveal Melanoma 88 Skin Neoplasms 88 Mycosis Fungoides 86 Sezary Syndrome 74 Carcinoma, Basal Cell 62 Neoplasm Metastasis 60 Lymphoma 59 Lymphoma, Non-Hodgkin 58 Keratosis, Actinic 58 Neoplasms 53 Leukemia, Lymphocytic, Chronic, B-Cell 52 Carcinoma, Renal Cell 50 Lymphoma, B-Cell, Marginal Zone 48 Carcinoma, Non-Small-Cell Lung 48 Lymphoma, Mantle-Cell 47 Lymphoma, Large B-Cell, Diffuse 47 Lymphoma, Follicular 47 Precursor Cell Lymphoblastic Leukemia-Lymphoma 46 Hodgkin Disease 46 Lymphoma, Large-Cell, Immunoblastic 45 Burkitt Lymphoma 44 Carcinoma, Merkel Cell 43 Brain Neoplasms 39 Multiple Myeloma 38 Lymphoma, Large-Cell, Anaplastic 36 Leukemia, Myeloid, Acute 36 Breast Neoplasms 36 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 34

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01395121 2017-06-08

NICAM

Institute of Cancer Research, United Kingdom

Phase 2 Completed

Mucosal Lentiginous Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡